Srinivas Akkaraju

Companies

• Kalaris Therapeutics, Inc.Board member Mar 18, 2025 to now¹
• ALUMIS INC.Board member Jun 27, 2024 to now²
• vTv Therapeutics Inc.Board member Feb 29, 2024 to now³
• Mineralys Therapeutics, Inc.Board member Feb 9, 2023 to now⁴
• Scholar Rock Holding CorpBoard member Jul 28, 2022 to now⁵
• Syros Pharmaceuticals, Inc.Board member Jun 12, 2017 to Sep 18, 2024⁶
• Intercept PharmaceuticalsBoard member Oct 10, 2012 to Nov 13, 2023⁷
• CHINOOK THERAPEUTICS, INC.Board member Oct 7, 2020 to Aug 11, 2023⁸
• Jiya Acquisition Corp.Board member Nov 18, 2020 to Sep 23, 2022⁹
• SeagenBoard member Apr 10, 2006 to May 19, 2020¹⁰
• Aravive, Inc.Board member Mar 20, 2014 to Dec 2, 2019¹¹
• Principia Biopharma (United States)Board member Sep 13, 2018 to Jan 10, 2019¹²
• aTyr PharmaBoard member May 6, 2015 to May 11, 2017¹³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SRScholar Rock Holding Corp SRRK6,395,585 shares¹⁴$260.8M at $40.78Jun 8, 2026
• MTMineralys Therapeutics, Inc. MLYS5,877,218 shares¹⁵$123.0M at $20.93Feb 20, 2026
• KTKalaris Therapeutics, Inc. KLRS11,448,081 shares¹⁶$21.9M at $1.91Dec 22, 2025
• AALUMIS INC. ALMS2,302,336 shares¹⁷$14.5M at $6.30Sep 9, 2026
• VTvTv Therapeutics Inc. VTVT206,784 shares¹⁸$5.8M at $28.09Sep 25, 2025
• Intercept Pharmaceuticals ICPT0 shares¹⁹Nov 8, 2023
• CTCHINOOK THERAPEUTICS, INC.0 shares²⁰Aug 11, 2023
• SPSyros Pharmaceuticals, Inc.1,795,760 shares²¹Sep 16, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Bought 273,290 shares at $10.63 of ALUMIS INC.¹⁷
• Sep 8, 2026Bought 273,291 shares at $10.63 of ALUMIS INC.¹⁷
• Sep 8, 2026Sold 48,065 shares at $10.55 of ALUMIS INC.¹⁷
• Sep 8, 2026Sold 48,066 shares at $10.55 of ALUMIS INC.¹⁷
• Sep 4, 2026Bought 220,070 shares at $11.17 of ALUMIS INC.¹⁷
• Sep 4, 2026Bought 220,070 shares at $11.17 of ALUMIS INC.¹⁷
• Jun 30, 2026Granted 3,553 shares of ALUMIS INC.²²
• Jun 4, 2026Granted 6,839 shares of Scholar Rock Holding Corp¹⁴
• Feb 19, 2026Granted 6,200 shares of Mineralys Therapeutics, Inc.¹⁵
• Jan 9, 2026Bought 588,235 shares at $17.00 of ALUMIS INC.²³
• Dec 22, 2025Granted 1,500,000 shares at $10.00 of Kalaris Therapeutics, Inc.¹⁶
• Dec 12, 2025Exercised 1,064,804 shares at $7.35 of Scholar Rock Holding Corp²⁴
• Dec 5, 2025Bought 51,380 shares at $10.73 of ALUMIS INC.²⁵
• Dec 5, 2025Bought 70,028 shares at $10.01 of ALUMIS INC.²⁵
• Dec 5, 2025Bought 64,969 shares at $8.95 of ALUMIS INC.²⁵
• Dec 4, 2025Bought 66,027 shares at $8.18 of ALUMIS INC.²⁶
• Dec 3, 2025Bought 100,000 shares at $7.75 of ALUMIS INC.²⁶
• Dec 2, 2025Bought 96,000 shares at $7.55 of ALUMIS INC.²⁶
• Dec 1, 2025Bought 86,350 shares at $7.46 of ALUMIS INC.²⁷
• Nov 28, 2025Bought 38,702 shares at $7.64 of ALUMIS INC.²⁷
• Nov 26, 2025Bought 48,537 shares at $7.64 of ALUMIS INC.²⁷
• Nov 20, 2025Bought 125,743 shares at $7.20 of ALUMIS INC.²⁸
• Nov 19, 2025Bought 137,772 shares at $6.56 of ALUMIS INC.²⁹
• Nov 18, 2025Bought 102,652 shares at $6.05 of ALUMIS INC.²⁹
• Nov 17, 2025Bought 914 shares at $5.51 of ALUMIS INC.²⁹